Question 1

What are the potential side effects of WID-RGC20 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia clinical trial (NCT05168007). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia clinical trial (NCT05168007). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if I experience worsening symptoms while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia clinical trial (NCT05168007). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any travel or logistical requirements I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia clinical trial (NCT05168007). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia clinical trial (NCT05168007). Contact the study team or your healthcare provider for specific answers.

What this study is about